VISITECT ® CD4 advanced disease assay in routine use: Diagnostic accuracy and usability, Ethiopia and Indonesia
Tropical Medicine & International Health · 2025
DOI: 10.1111/tmi.14124 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tropical Medicine & International Health, 2025. Verfasst von Petra de Haas und 11 weiteren Autor:innen. Beteiligte Einrichtung: KNCV Tuberculosis Foundation, The Hague, The Netherlands. Hauptthemen laut MEDLINE: HIV Infections, Point-of-Care Systems. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
We assessed the diagnostic accuracy and usability of the rapid semiquantitative point of care VISITECT® CD4 Advanced Disease Assay, compared to routinely obtained CD4 counts among people living with HIV in Ethiopia and Indonesia. We consecutively enrolled people living with HIV aged ≥10 years who were newly diagnosed, had interrupted antiretroviral treatment for ≥3 months, or were feeling unwell. Venous blood was drawn to obtain CD4 counts on routinely available test instruments and a VISITECT® CD4 Advanced Disease Assay result. The sensitivity of VISITECT® CD4 Advanced Disease Assay was high (97.8%, 95% confidence interval [CI], 94.4–99.4%), but the specificity was low (32.7%, 95%CI, 27.9–37.8%). It significantly increased to 42.5% (95%CI, 33.2–52.1%) after retraining of laboratory staff, but remained low. The low specificity of VISITECT® CD4 Advanced Disease Assay was due to poor capacity in test reading by routine staff. Reading the test strip is error‐prone and requires intensive and regular training. Reading aids may improve the usability of this essential point of care test.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- KNCV Tuberculosis Foundation, The Hague, The Netherlands.
- KNCV Tuberculosis Foundation Ethiopia Office, Addis Ababa, Ethiopia.
- Yayasan KNCV Indonesia, Jakarta, Indonesia.
- Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
- Division of Tropical Medicine and Infectious Diseases, Department of Internal Medicine, Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
- Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
ORCID-Profile: Petra de Haas, Erni Juwita Nelwan, Edine Tiemersma
Zitieren
APA
de Haas, P., Hepple, P., Babo, Y., Srioetami, F., Amare, M., Sherefdin, B., Slyzkyi, A., Widyaputri, D., Nelwan, E. J., Sugiharto, J., Bedru, A., & Tiemersma, E. (2025). VISITECT ® CD4 advanced disease assay in routine use: Diagnostic accuracy and usability, Ethiopia and Indonesia. Tropical Medicine & International Health. https://doi.org/10.1111/tmi.14124
Vancouver
de Haas P, Hepple P, Babo Y, Srioetami F, Amare M, Sherefdin B, et al. VISITECT ® CD4 advanced disease assay in routine use: Diagnostic accuracy and usability, Ethiopia and Indonesia. Tropical Medicine & International Health. 2025. doi:10.1111/tmi.14124
BibTeX
@article{deHaas2025,
author = {de Haas, Petra and Hepple, Pamela and Babo, Yohannes and Srioetami, Francisca and Amare, Misikir and Sherefdin, Bihil and Slyzkyi, Andrii and Widyaputri, Denisa and Nelwan, Erni Juwita and Sugiharto, Jhon and Bedru, Ahmed and Tiemersma, Edine},
title = {VISITECT ® CD4 advanced disease assay in routine use: Diagnostic accuracy and usability, Ethiopia and Indonesia},
journal = {Tropical Medicine & International Health},
year = {2025},
doi = {10.1111/tmi.14124}
}
EUVIMED